Semax (ACTH 4-7 analog): a heptapeptide with demonstrated neuroprotective signal

Semax (ACTH 4-7 analog): a heptapeptide with demonstrated neuroprotective signal

Semax is a synthetic heptapeptide built as ACTH(4–7) with a C-terminal Pro-Gly-Pro (PGP) extension. The one-letter sequence is MEHFPGP: Met-Glu-His-Phe-Pro-Gly-Pro. It is not adrenocorticotropin. It is not ACTH(1–24). It is not ACTH(4–10) without the PGP tail. Catalogs that print “Semax” without the seven-letter string have not identified the reagent.

This article is an identity note for laboratory sourcing. Rodent papers exist; they are not a medicine label. This catalog’s listing is a research-use-only peptide, not a registered drug product from any jurisdiction.

RUO. Semax on this site is listed for laboratory research only. Not for human or veterinary use. Not a medicine, nootropic product, or nasal preparation. This listing is not the Russian registered drug. Public CAS and sequence are literature identifiers. Lot identity is the observed mass and the sequence on the COA when one is issued.

The published heptapeptide

PubChem indexes the peptide as CID 9811102 under the title ACTH (4–7), Pro-Gly-Pro-. The computed formula is C37H51N9O10S and the molecular weight is 813.9 g/mol. The public CAS is 80714-61-0.1

FieldPublic listing (PubChem)
Common nameSemax; ACTH(4–7)-PGP
SequenceMEHFPGP / H-Met-Glu-His-Phe-Pro-Gly-Pro-OH
PubChem CID9811102
CAS80714-61-0
FormulaC37H51N9O10S
MW813.9 g/mol
Parent fragmentACTH residues 4–7 (MEHF) plus PGP

The methionine side chain is the sulfur in that formula. Oxidation of Met to sulfoxide is a known process impurity class for Met-containing peptides; it is a different mass. A COA that never mentions methionine chemistry has not finished identity work. We do not print a house oxidation percentage.

ACTH(4–7)-PGP is not ACTH

Adrenocorticotropic hormone is a 39-residue peptide in the human sequence. Residues 4–10 of ACTH are Met-Glu-His-Phe-Arg-Trp-Gly. Semax keeps 4–7 (MEHF) and replaces the rest of that span with Pro-Gly-Pro. The result is seven residues, not ten, and not thirty-nine. Calling a MEHFPGP vial “ACTH” or “ACTH(4–10)” is a mislabel.

Practical checks on a lot document:

N-terminal acetylation, C-terminal amidation, and Met(O) are three independent ways to leave the PubChem formula. Each must be named if it is what was synthesized.

Rodent literature is not a drug label

Dolotov and colleagues reported that Semax binds and increases BDNF protein levels in rat basal forebrain in a Journal of Neurochemistry study.2 That paper is rodent laboratory literature. It is cited here so a sourcing file can see the analogue named in a peer-reviewed methods context — ACTH(4–10) analogue language in the title, heptapeptide in practice — not as a clinical claim, not as a cognitive protocol, and not as a reason this catalog exists.

BioLabs Research does not sell Semax as a nootropic, a stroke medicine, or an intranasal product. If a methods section needs the Dolotov paper, it needs the paper, not a storefront paragraph.

This catalog is not the Russian registered drug

Semax has a history as a registered medicinal product in the Russian Federation under that trade name. A lyophilized research-reagent listing on an RUO catalog is not that product. It does not inherit a marketing authorization, a pharmacopoeial monograph, an approved nasal spray device, or a labeled indication. Putting the same seven letters on a vial does not make a drug.

Buyers who need a licensed medicinal product must buy a licensed medicinal product from a licensed channel. This site does not offer that channel. The RUO vial is a chemical, identified by sequence and mass.

Mass, salt, and what we will not print

The 813.9 g/mol figure is the PubChem molecular weight for the free peptide. TFA or acetate counter-ions and residual water change the mass of the powder you weigh. HPLC area% does not capture that. If the experiment is quantitative, demand net peptide content on the lot COA, as in the HPLC note. We will not invent an HPLC% or an NPC% for this SKU.

Related notes: HPLC area% vs net peptide content and How a Serious Lot Is Read.

Catalog card

The Semax catalog page lists the heptapeptide as a laboratory reagent with public identifiers and lot COA on request. Match MEHFPGP and CAS 80714-61-0 to the COA. If those lines disagree, the lot is not the listing.

The mind is not a vessel to be filled but a fire to be kindled. — Plutarch

Semax listing

Research-use-only heptapeptide MEHFPGP. Not the Russian registered drug. Sequence and CAS as public identity. Lot paper on request.

View Semax →

References

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 9811102, ACTH (4-7), Pro-Gly-Pro-. Formula C37H51N9O10S; MW 813.9 g/mol; CAS 80714-61-0. https://pubchem.ncbi.nlm.nih.gov/compound/9811102
  2. Dolotov OV, Karazeeva EP, Inozemtseva LS, et al. Semax, an analogue of adrenocorticotropin (4–10), binds specifically and increases levels of BDNF protein in rat basal forebrain. J Neurochem. 2006. PMID 16635254. Cited as rodent laboratory literature naming the analogue, not as a medicine claim. https://doi.org/10.1111/j.1471-4159.2006.03658.x